相关实验视频

Updated: Jun 11, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

RFWD2增加了骨髓瘤细胞的增殖和CDDP抵抗力

Pingting Liu¹, Na Xie²

¹Department of Health Management Center, Hunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, China.

|September 30, 2024

概括

在骨髓瘤中,RFWD2充当瘤基因,促进瘤生长并影响化疗反应. 针对RFWD2为骨髓瘤患者提供了一个新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

在骨髓瘤中,P53突变很常见,影响瘤抑制基因活性.
无素蛋白酶体系统调节细胞过程,包括瘤发育.
RFWD2是一种E3泛素酶,与瘤进展有关,但其在骨髓瘤中的作用需要澄清.

研究的目的:

为了研究RFWD2在具有不同p53基因状态的骨髓瘤中的作用.
为了确定RFWD2是否影响骨髓瘤细胞增殖,侵袭和化学敏感性.
探索RFWD2作为骨髓瘤治疗点的潜力.

主要方法:

分析TCGA数据以将RFWD2表达与患者存活率相关联.
在体外测试 (CCK-8,殖民地形成,Transwell) 和体内异种移植模型来评估RFWD2的功能.
共同免疫沉 (Co-IP) 来研究RFWD2-p53相互作用.
实验评估RFWD2对骨髓瘤细胞对CDDP敏感性的影响.

主要成果:

在骨髓瘤患者中,高RFWD2表达与较短的存活率相关.
在不同的p53状态中,RFWD2促进骨髓瘤细胞的增殖和侵入.
在具有突变或野生类型p53.3的骨髓瘤细胞中,RFWD2与p53相互作用.
RFWD2调节骨髓瘤细胞对CDDP治疗的敏感性.

结论:

在骨髓瘤中,RFWD2作为瘤基因起作用.
RFWD2调节骨髓瘤细胞的增殖,入侵和对CDDP的反应.
RFWD2代表了骨髓瘤治疗的潜在治疗标.

关键词:

在CDDP中,CDDP是指CDDP.骨质肉瘤骨质肉瘤是什么这就是RFWD2 RFWD2.在 p53 里,p53 是一个 p53 号码.

更多相关视频

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...